List of insiders holdings for Blueprint Medicines Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | LEVIN MARK J 10% Owner |
2017-03-20 16:21:02 | 111,244 3,453,753 |
3,564,997 | Form 4 |
| 2 | FMR LLC See Remark 1 |
2025-02-12 09:16:22 | 2,247,679 0 |
2,247,679 | Form 13G |
| 3 | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
2019-02-13 16:04:32 | 1,022,165 0 |
1,022,165 | Form 13G |
| 4 | Kuvalanka Kyle D. Chief Business Officer |
2015-04-30 07:17:30 | 187,271 0 |
187,271 | Form 3 |
| 5 | LYNCH DANIEL Director |
2020-06-26 16:08:05 | 132,404 0 |
132,404 | Form 4 |
| 6 | Lydon Nicholas Director |
2024-06-14 17:34:57 | 62,596 0 |
62,596 | Form 4 |
| 7 | Lengauer Christoph Chief Scientific Officer |
2016-04-14 17:55:33 | 56,657 0 |
56,657 | Form 4 |
| 8 | Dorsch Marion Chief Scientific Officer |
2021-02-24 16:28:01 | 55,672 0 |
55,672 | Form 4 |
| 9 | Boral Anthony L. Chief Medical Officer |
2020-12-16 16:03:37 | 35,630 0 |
35,630 | Form 4 |
| 10 | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
2024-03-11 18:24:10 | 33,853 0 |
33,853 | Form 4 |
| 11 | Demetri George Director |
2022-06-30 21:53:27 | 13,712 0 |
13,712 | Form 4 |
| 12 | Tango Therapeutics Inc. Director |
2021-12-10 16:25:29 | 10,400 0 |
10,400 | Form 4 |
| 13 | Rowland Charles A Jr Director |
2021-06-04 16:16:55 | 10,312 0 |
10,312 | Form 4 |
| 14 | Landsittel Michael Chief Financial Officer |
2025-07-21 19:50:39 | 0 0 |
0 | Form 4 |
| 15 | Dable Habib J Director |
2025-07-21 19:50:07 | 0 0 |
0 | Form 4 |
| 16 | Hurley Ariel Principal Accounting Officer |
2025-07-21 19:49:33 | 0 0 |
0 | Form 4 |
| 17 | Tsai John Director |
2025-07-21 19:49:11 | 0 0 |
0 | Form 4 |
| 18 | COATS LONNEL Director |
2025-07-21 19:49:03 | 0 0 |
0 | Form 4 |
| 19 | Hewes L. Becker Chief Medical Officer |
2025-07-21 19:48:28 | 0 0 |
0 | Form 4 |
| 20 | Seely Lynn Director |
2025-07-21 19:48:10 | 0 0 |
0 | Form 4 |
| 21 | Carter Percy H. Chief Scientific Officer |
2025-07-21 19:47:42 | 0 0 |
0 | Form 4 |
| 22 | Rossi Christina Chief Operating Officer |
2025-07-21 19:47:28 | 0 0 |
0 | Form 4 |
| 23 | Haviland Kate Chief Executive Officer |
2025-07-21 19:47:19 | 0 0 |
0 | Form 4 |
| 24 | Borisy Alexis Director |
2025-07-21 19:46:35 | 0 0 |
0 | Form 4 |
| 25 | Goldberg Mark Alan Director |
2025-07-21 19:46:05 | 0 0 |
0 | Form 4 |
| 26 | Namouni Fouad PRESIDENT, R & D |
2025-07-21 19:45:46 | 0 0 |
0 | Form 4 |
| 27 | Beckman Daniella Director |
2025-07-21 19:45:29 | 0 0 |
0 | Form 4 |
| 28 | McCain Tracey L EVP & Chief Legal Officer |
2025-07-21 19:45:09 | 0 0 |
0 | Form 4 |
| 29 | Durso-Bumpus Debra Chief People Officer |
2025-07-21 19:44:38 | 0 0 |
0 | Form 4 |
| 30 | Lee Philina Chief Commercial Officer |
2025-07-21 19:44:30 | 0 0 |
0 | Form 4 |
| 31 | Albers Jeffrey W. Director |
2025-07-21 19:44:02 | 0 0 |
0 | Form 4 |